Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CYAN | Cyanotech Corporation Common Stock | Purchase | $3.8K | +5K | +0.34% | $0.76 | 1.47M | Oct 1, 2024 | By self as trustee of the Michael Arlen Davis Revocable Trust | F1 |
transaction | CYAN | Cyanotech Corporation Common Stock | Award | $10K | +13.2K | +0.9% | $0.76 | 1.48M | Oct 1, 2024 | By self as trustee of the Michael Arlen Davis Revocable Trust | F2 |
holding | CYAN | Cyanotech Corporation Common Stock | 12.1K | Oct 3, 2024 | Direct | ||||||
holding | CYAN | Cyanotech Corporation Common Stock | 31.3K | Oct 3, 2024 | By Spouse | ||||||
holding | CYAN | Cyanotech Corporation Common Stock | 150K | Oct 3, 2024 | By self as co-trustee for the Nyracai Davis Irr. Trust and the Nettizanne J. Davis Irr. Trust | ||||||
holding | CYAN | Cyanotech Corporation Common Stock | 58K | Oct 3, 2024 | By self as trustee for Nettizanne Johnstone Davis GST Exempt Trust | ||||||
holding | CYAN | Cyanotech Corporation Common Stock | 58.8K | Oct 3, 2024 | By self as trustee for Nyracai Johnstone Davis GST Exempt Trust |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Id | Content |
---|---|
F1 | Adoption date of referenced 10b5-1(c) plan is: 03-06-2024 |
F2 | To reduce the Company's ongoing cash expense, the Nominating and Corporate Governance Committee of the Board of Directors adopted a resolution allowing each director to elect to receive his quarterly director fees in the form of restricted stock in lieu of cash. The Reporting Person elected to receive shares of restricted stock in lieu of cash for the second quarter of fiscal 2025. |